DIPHENHYDRAMINE Drug Patent Profile
✉ Email this page to a colleague
When do Diphenhydramine patents expire, and what generic alternatives are available?
Diphenhydramine is a drug marketed by Alra, Anabolic, Elkins Sinn, Fosun Pharma, Halsey, Heather, Heritage Pharma, Hikma Intl Pharms, Impax Labs, Ivax Sub Teva Pharms, Lannett, Lederle, LNK, Mk Labs, Mutual Pharm, Newtron Pharms, Nexgen Pharma Inc, Perrigo, Pioneer Pharms, Purepac Pharm, Pvt Form, Roxane, Sun Pharm Industries, Superpharm, Teva, Valeant Pharm Intl, Vangard, Watson Labs, Whiteworth Town Plsn, Bundy, Cenci, Kv Pharm, Naska, Pharm Assoc, App Pharms, Avet Lifesciences, Bel Mar, Dr Reddys, Gland, Hikma, Hospira, Lyphomed, Micro Labs, Pharmobedient, West-ward Pharms Int, Wyeth Ayerst, Alpharma Us Pharms, Cumberland Swan, Sciegen Pharms, Abraxis Pharm, Fresenius Kabi Usa, and Intl Medication. and is included in seventy-eight NDAs.
The generic ingredient in DIPHENHYDRAMINE is diphenhydramine hydrochloride. There are twenty-three drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the diphenhydramine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Diphenhydramine
A generic version of DIPHENHYDRAMINE was approved as diphenhydramine hydrochloride by WEST-WARD PHARMS INT on December 31st, 1969.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DIPHENHYDRAMINE?
- What are the global sales for DIPHENHYDRAMINE?
- What is Average Wholesale Price for DIPHENHYDRAMINE?
Summary for DIPHENHYDRAMINE
| US Patents: | 0 |
| Applicants: | 52 |
| NDAs: | 78 |
| Drug Prices: | Drug price information for DIPHENHYDRAMINE |
| DailyMed Link: | DIPHENHYDRAMINE at DailyMed |



